Comparative Study of Haemodynamic Changes After Spinal Anaesthesia in Non-obese and Pregnant Women
1 other identifier
interventional
60
1 country
1
Brief Summary
Obesity has become one of the most common risk factors in obstetric practice with serious anaesthetic implications. Obese pregnants have limited physiological reserves and cardiovascular co- morbidities when compared to non-obese pregnant women. Spinal anaesthesia is the anaesthetic technique of choice for caesarean section. The haemodynamic changes associated with spinal anaesthesia pose the greatest hazard to the mother and the foetus and are exaggerated in obese pregnant women. However differences in the changes in haemodynamic variables such as cardiac output (CO), stroke volume (SV) and systemic vascular resistance (SVR) between obese and non-obese pregnant women having caesarean section (CS) under spinal anaesthesia have not been studied before. This study compares the haemodynamic changes after spinal anaesthesia for CS in non-obese and obese parturients in a single centre, prospective case control study, using LiDCOrapidV2. This LiDCOrapidV2 device is a noninvasive method of measuring haemodynamic variables. It is a single centre, prospective, case control study. The primary outcome compares the differences and variability in CO, SV and SVR between obese and non-obese parturients. The secondary outcomes include comparison of the correlation between changes in blood pressure (BP) and CO in each patient and the difference in BP between conventional intermittent oscillometric device and continuous LiDCORapidV2in each patient with a view to assess the need for measurement of cardiac output in obstetric anaesthesia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 15, 2014
CompletedFirst Posted
Study publicly available on registry
November 6, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedSeptember 8, 2016
September 1, 2016
1.7 years
December 15, 2014
September 7, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in the variation of cardiac output (CO) from baseline values between obese and non-obese parturients after spinal anaesthesia.
The change in cardiac output from baseline measured as milliliters/minute at predetermined intervals after spinal anaesthesia will be recorded in each group. The mean value of this change in each group will be compared for each recording and the difference in the change between the two groups will be reported.
18 months
Secondary Outcomes (1)
Mean difference in the amount of vasopressors infused in millilitres/hour between non-obese and obese pregnant women.
12 months
Study Arms (2)
BMI less than 30
ACTIVE COMPARATORThe drop in cardiac output after spinal anaesthesia for LSCS at various intervals with LiDCORapid
BMI more than 40
EXPERIMENTALThe drop in cardiac output after spinal anaesthesia for LSCS at various intervals with LiDCORapid
Interventions
Cardiac output will be non invasively monitored by using 2 cuffs on fingers.
Eligibility Criteria
You may qualify if:
- Pregnant patients with BMI of less than 30 undergoing elective CS.
- Obese pregnant patients with BMI of more than 35 undergoing elective CS
You may not qualify if:
- Patients with other comorbidities like pre-eclampsia, eclampsia, essential hypertension, respiratory disease and compromised renal function.
- Patients on long-term medication.
- Patients having CS under epidural.
- Patients having general anaesthesia.
- Patients on antihypertensive medication.
- Patients with BMI of 31-34.
- Patients less than 36 weeks of gestation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aberdeen Maternity Hospital
Aberdeen, Aberdeen, AB25 2ZN, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manisha Kumar, FRCA
NHS Grampian
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2014
First Posted
November 6, 2015
Study Start
December 1, 2014
Primary Completion
August 1, 2016
Study Completion
August 1, 2016
Last Updated
September 8, 2016
Record last verified: 2016-09
Data Sharing
- IPD Sharing
- Will not share